FTC sues major pharmacy reward managers over insulin price ranges The agency introduced motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the checklist price of lifestyle-saving insulin medications. Investment in digital health companies achieved decades-reduced levels final calendar year after star... https://edgarnevka.theblogfairy.com/30071705/not-known-factual-statements-about-healthcare-news